These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35868667)

  • 1. Inflammaging at the Time of COVID-19.
    Zazzara MB; Bellieni A; Calvani R; Coelho-Junior HJ; Picca A; Marzetti E
    Clin Geriatr Med; 2022 Aug; 38(3):473-481. PubMed ID: 35868667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
    Xu K; Wei Y; Giunta S; Zhou M; Xia S
    Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosenescence, Inflammaging and Resilience: An Evolutionary Perspective of Adaptation in the Light of COVID-19 Pandemic.
    Banić M; Pleško S; Urek M; Babić Ž; Kardum D
    Psychiatr Danub; 2021; 33(Suppl 4):427-431. PubMed ID: 34718260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome.
    Buonsenso D; Piazza M; Boner AL; Bellanti JA
    Allergy Asthma Proc; 2022 May; 43(3):187-193. PubMed ID: 35524358
    [No Abstract]   [Full Text] [Related]  

  • 5. How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19.
    Müller L; Di Benedetto S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From aging to long COVID: exploring the convergence of immunosenescence, inflammaging, and autoimmunity.
    Müller L; Di Benedetto S
    Front Immunol; 2023; 14():1298004. PubMed ID: 37942323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosenescence and Inflammaging in COVID-19.
    Asghari F; Asghary A; Majidi Zolbanin N; Faraji F; Jafari R
    Viral Immunol; 2023 Nov; 36(9):579-592. PubMed ID: 37797216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People.
    Pietrobon AJ; Teixeira FME; Sato MN
    Front Immunol; 2020; 11():579220. PubMed ID: 33193377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?
    Santoro A; Bientinesi E; Monti D
    Ageing Res Rev; 2021 Nov; 71():101422. PubMed ID: 34391943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.
    Acosta-Ampudia Y; Monsalve DM; Rojas M; Rodríguez Y; Zapata E; Ramírez-Santana C; Anaya JM
    J Infect Dis; 2022 Jun; 225(12):2155-2162. PubMed ID: 35079804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanism of -Acute Sarcopenia in Elderly Patient with COVID - 19.
    Aryana IGPS; Setiati S; Rini SS
    Acta Med Indones; 2021 Oct; 53(4):481-492. PubMed ID: 35027498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19.
    Omarjee L; Perrot F; Meilhac O; Mahe G; Bousquet G; Janin A
    Aging (Albany NY); 2020 Dec; 12(24):26263-26278. PubMed ID: 33361522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging, inflammaging and immunosenescence as risk factors of severe COVID-19.
    Tizazu AM; Mengist HM; Demeke G
    Immun Ageing; 2022 Nov; 19(1):53. PubMed ID: 36369012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
    Moreno Fernández-Ayala DJ; Navas P; López-Lluch G
    Exp Gerontol; 2020 Dec; 142():111147. PubMed ID: 33171276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
    Pinheiro MM; Fabbri A; Infante M
    Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes.
    Sabbatinelli J; Matacchione G; Giuliani A; Ramini D; Rippo MR; Procopio AD; Bonafè M; Olivieri F
    Mech Ageing Dev; 2022 Jun; 204():111667. PubMed ID: 35341896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.